| Literature DB >> 31655434 |
A Herbert1, S Winters2, S McPhail2, L Elliss-Brookes2, G Lyratzopoulos3, G A Abel4.
Abstract
BACKGROUND: Diagnosis of cancer through an emergency presentation is associated with worse clinical and patient experience outcomes. The proportion of patients with cancer who are diagnosed through emergency presentations has consequently been introduced as a routine cancer surveillance measure in England. Welcome reductions in this metric have been reported over more than a decade but whether reductions reflect true changes in how patients are diagnosed rather than the changing case-mix of incident cohorts in unknown.Entities:
Keywords: Case-mix; Diagnosis; Emergency; Inequalities; Neoplasm; Public health
Year: 2019 PMID: 31655434 PMCID: PMC6905147 DOI: 10.1016/j.canep.2019.101574
Source DB: PubMed Journal: Cancer Epidemiol ISSN: 1877-7821 Impact factor: 2.984
Fig. 1Crude and predicted* proportions of emergency presentation by year of diagnosis.
*Had sex, age group, deprivation group, and cancer site case-mix stayed the same as in 2006. Predictions made using a logistic regression model fitted to 2006-15 data, where emergency presentation was the outcome, and independent variables were diagnosis year, sex, age group, deprivation group, cancer site, and interaction terms sex*cancer site, age group*cancer site, and deprivation*cancer site.
Crude and predicted proportions of emergency presentations in 2015 (had the patient case-mix [overall and by individual case-mix variable] remained the same as in 2006).
| Crude (observed) % of emergency presentations | Predicted based on all case-mix variables | Predicted based only on sex | Predicted based only on age | Predicted based only on deprivation | Predicted based only on cancer site | |
|---|---|---|---|---|---|---|
| 2006 (N = 237,799) | 23.81 | 23.81 | 23.81 | 23.81 | 23.81 | 23.81 |
| 2015 (N = 285,660) | 19.15 | 20.04 | 19.14 | 19.23 | 19.33 | 19.90 |
| Absolute change in % between 2006 and 2015 | −4.66 | −3.77 | −4.67 | −4.58 | −4.48 | −3.91 |
| % of the crude absolute reduction that is explained by case-mix changes | . | 19.04 | −0.19 | 1.78 | 3.85 | 16.01 |
Had sex, age group, deprivation group, and cancer site case-mix stayed the same as in 2006. Predictions made using a logistic regression model fitted to 2006-15 data, where emergency presentation was the outcome, and independent variables were year, sex, age group, deprivation group, and cancer site, and interaction terms for sex*cancer site, age group*cancer site, and deprivation group*cancer site.
Had sex (or age group, deprivation group, or cancer site) case-mix stayed the same as in 2006. Predictions made using a logistic regression model fitted to 2006-15 data, where emergency presentation was the outcome, and independent variables were year and sex (or age group, deprivation group, or cancer site).
Calculated as c–d where c = Crude (or Predicted) proportion in 2015 and d = Crude (or Predicted) proportion in 2006. Calculations based on proportions to five decimal places. E.g. For predicted proportions where all case-mix stayed the same throughout study period, 20.03882–23.81171=--3.77289.
Calculated as 100(e–f)/e, where e = Crude proportion in 2015-Crude proportion in 2006, and f = Predicted proportion in 2015-Predicted proportion in 2006. Calculations based on proportions to five decimal places. E.g. For all case-mix, 100((19.15162–23.81171)-(20.03882–23.81171))/(19.15162–23.81171) = 19.03826.
The 2007 version of Index of Multiple Deprivation was used for diagnosis year 2006, 2010 version for diagnosis years 2007–2009, and the 2015 version for diagnosis years 2010–2015.
Fig. 2Relative proportion* of observed absolute decrease (between 2006 and 2015) in EPs attributable to changes in cancer site case-mix (overall [blue bar] and individual cancer sites [red bars]). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).
*Had sex, age group, deprivation group, and cancer site case-mix stayed the same as in 2006. Predictions made using a logistic regression model fitted to 2006-15 data, where emergency presentation was the outcome, and independent variables were: year and a) in the case of all cancer sites, a variable for cancer site; b) in the case of each individual cancer site, a dummy variable representing that particular site.
ALL = Acute Lymphoblastic Leukaemia; AML = Acute Myeloid Leukaemia; CLL = Chronic Lymphocytic Leukaemia; CML = Chronic Myeloid Leukaemia; CUP = Cancer of Unknown Primary; HL = Hodgkin Lymphoma; NHL = Non-Hodgkin Lymphoma.
Fig. 3Change in the relative frequency of each studied cancer-site (between 2006 and 2015) plotted against the cancer site-specific risk of EP (in 2006).
Certain cancers with relatively low risk (e.g. melanoma) are becoming more common (top-left quadrant), while some with relatively high risk less common (lung, bottom-right quadrant). All other factors being equal, these would contribute to downward trends. Contrasting patterns are observed in, for example, rectal and liver cancer (bottom-left and top-right quadrants). These observations help to further interpret and contextualise the findings, and should be interpreted together with Appendix 6 and estimates from the main analysis model, indicating that the ‘net’ (overall) effect of cancer site case-mix changes over time contributes to decreasing trends.
*The overall risk of EP, across the 35 cancers studied.
ALL = Acute Lymphoblastic Leukaemia; AML = Acute Myeloid Leukaemia; CLL = Chronic Lymphocytic Leukaemia; CML = Chronic Myeloid Leukaemia; EP = Emergency presentation; HL = Hodgkin Lymphoma; NHL = Non-Hodgkin Lymphoma.